tradingkey.logo

Harvard Bioscience Inc <HBIO.OQ> expected to post earnings of 5 cents a share - Earnings Preview

ReutersMar 10, 2025 12:56 PM
  • Harvard Bioscience Inc HBIO.OQ HBIO.O is expected to show a fall in quarterly revenue when it reports results on March 12 for the period ending December 31 2024

  • The Holliston Massachusetts-based company is expected to report a 14.2% decrease in revenue to $24.15 million from $28.15 million a year ago, according to the mean estimate from 2 analysts, based on LSEG data.The company's guidance on November 7 2024, for the period ended December 31, was for revenue between $23.00 million and $26.00 million.

  • ​LSEG's mean analyst estimate for Harvard Bioscience Inc is for earnings of 5 cents per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Harvard Bioscience Inc is $6.25​, above​ its last closing price of $0.82. ​​​

The company's guidance on November 7 2024 for the period ended December 31 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD23 million and USD4.16 million.The company's guidance on November 7 2024 for the period ended December 31 was for gross profit margin between USD59% and USD60%.

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING

STARMINESMARTESTIMATE®

LSEG IBES ESTIMATE

ACTUAL

BEAT, MET, MISSED

SURPRISE %

Sep. 30 2024

0.02

0.03

-0.02

Missed

-175

Jun. 30 2024

0.03

0.05

0.00

Missed

-100

Mar. 31 2024

0.02

0.02

0.02

Met

-14.3​

Dec. 31 2023

0.05

0.05

0.04

Missed

-20

​​Sep. 30 2023

0.04

0.04

0.01

Missed

-75

Jun. 30 2023

0.07

0.06

0.04

Missed

-36.8​

Mar. 31 2023

0.05

0.05

0.06

Beat

20

Dec. 31 2022

0.08

0.03

0.04

Beat

20

This summary was machine generated March 10 at 12:56 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI